Cybin Inc. Common Stock
HELP
Rangering i aksjer
#11636
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Aksjekurs
$10.30
Sist synkronisert: 2026-08-11
Markedsverdi
$638.32M
Endring (1 dag)
2.88%
Endring (1 år)
9,119.52%
Land
CA
Handel Cybin Inc. Common Stock (HELP)
Kategori
Healthcare
Historikk for aksjesplitt for Cybin Inc. Common Stock (HELP)
Aksjen Cybin Inc. Common Stock (symbol: HELP) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én HELP-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 HELP-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én HELP-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 HELP-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
